Control of type II transforming growth factor-β receptor expression by integrin ligation

被引:45
|
作者
Wang, DH
Sun, LZ
Zborowska, E
Willson, JKV
Gong, JG
Verraraghavan, J
Brattain, MG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
[3] Univ Kentucky, Dept Pharmacol, Lexington, KY 40536 USA
[4] Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA
[5] Sch Med, Cleveland, OH 44106 USA
[6] Med Coll Ohio, Dept Biochem, Toledo, OH 43699 USA
关键词
D O I
10.1074/jbc.274.18.12840
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ectopic expression of the alpha(5) integrin subunit in cancer cells with little or no endogenous expression of this integrin often results in reduced proliferation as well as reduced malignancy, We now show that inhibition resulting from ectopic expression of alpha(5) integrin is due to induction of autocrine negative transforming growth factor-beta (TGF-beta) activity. MCF-7 breast cancer cells do not express either alpha(5) integrin or type II TGF-beta receptor and hence are unable to generate TGF-beta signal transduction. Ectopic expression of cy,integrin expression enhanced cell adhesion to fibronectin, reduced proliferation, and increased the expression of type II TGF-beta receptor mRNA and cell surface protein. Receptor expression was increased to a higher level in alpha(5) transfectants by growth on fibronectin-coated plates. Induction of type II TGF-beta receptor expression also resulted in the generation of autocrine negative TGF-beta activity because colony formation was increased after TGF-beta neutralizing antibody treatment. Transient transfection with a TGF-beta promoter response element in tandem with a luciferase cDNA into cells stably transfected with cu, integrin resulted in basal promoter activities 5-10-fold higher than those of control cells. Moreover, when alpha(5) transfectants were treated with a neutralizing antibody to either TGF-beta or integrin alpha(5), this increased basal promoter activity was blocked, Autocrine TGF-beta activity also induced 3-fold higher endogenous fibronectin expression in alpha(5) transfectants relative to that of control cells, Re-expression of type II receptor by alpha(5) transfection also restored the ability of the cells to respond to exogenous TGF-beta and led to reduced tumor growth in athymic nude mice. Taken together, these results show for the first time that TGF-beta type II receptor expression can be controlled by alpha(5)beta(1) ligation and integrin signal transduction, Moreover, TGF-beta and integrin signal transduction appear to cooperate in their tumor-suppressive functions.
引用
收藏
页码:12840 / 12847
页数:8
相关论文
共 50 条
  • [1] Expression of transforming growth factor-β type I receptor and transforming growth factor-β type II receptor in rat retina
    Shen, Wei
    Liu, Lin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2009, 2 (03) : 204 - 206
  • [2] Expression of transforming growth factor-β type 1 receptor and transforming growth factor-β type 2 receptor in diabetic rat retina
    Cao, Dan
    Liu, Lin
    Shen, Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2008, 1 (04) : 297 - 300
  • [3] Lack of transforming growth factor-β type II receptor expression in human retinoblastoma cells
    Horie, K
    Yamashita, H
    Mogi, A
    Takenoshita, S
    Miyazono, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 175 (03) : 305 - 313
  • [4] Integrin control of the transforming growth factor-β pathway in glioblastoma
    Roth, Patrick
    Silginer, Manuela
    Goodman, Simon L.
    Hasenbach, Kathy
    Thies, Svenja
    Maurer, Gabriele
    Schraml, Peter
    Tabatabai, Ghazaleh
    Moch, Holger
    Tritschler, Isabel
    Weller, Michael
    BRAIN, 2013, 136 : 564 - 576
  • [5] Enhanced Expression of Growth Factor-β Type II Receptor
    Kharazmi, Sara
    Baghizadeh, Amin
    Torkzadeh-Mahani, Masoud
    BIOPHARM INTERNATIONAL, 2018, 31 (03) : 28 - 36
  • [6] Induction of angiogenesis by expression of soluble type II transforming growth factor-β receptor in mouse hepatoma
    Kim, KY
    Jeong, SY
    Won, J
    Ryu, PD
    Nam, MJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38781 - 38786
  • [7] Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β
    F Vincent
    M Nagashima
    S Takenoshita
    M A Khan
    A Gemma
    K Hagiwara
    W P Bennett
    Oncogene, 1997, 15 : 117 - 122
  • [8] Possible involvement of transforming growth factor-β1 and transforming growth factor-β receptor type II during luteinization in the marmoset ovary
    Wehrenberg, U
    Giebel, J
    Rune, GM
    TISSUE & CELL, 1998, 30 (03): : 360 - 367
  • [9] Transforming growth factor-β-induced upregulation of transforming growth factor-β receptor expression in pancreatic regeneration
    Menke, A
    Geerling, I
    Giehl, K
    Vogelmann, R
    Reinshagen, M
    Adler, G
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1449 (02): : 178 - 185
  • [10] Expression of cavernous transforming growth factor-β1 and its Type II Receptor in patients with erectile dysfunction
    Ryu, JK
    Han, JY
    Chu, YC
    Song, SU
    Lee, KH
    Yoon, SM
    Suh, JK
    Kim, SJ
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2004, 27 (01): : 42 - 49